Decreased cutaneous reactions to kallikrein in patients with atopic dermatitis and psoriasis.
D000152:Acne Vulgaris; D000293:Adolescent; D000328:Adult; D001920:Bradykinin / Q000494:pharmacology; D003876:Dermatitis, Atopic; D004342:Drug Hypersensitivity; D004485:Eczema; D005260:Female; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D007271:Injections, Intradermal; D007610:Kallikreins / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis; D012867:Skin / Q000187:drug effects*; D012871:Skin Diseases
D006632:Histamine; D007610:Kallikreins; D001920:Bradykinin